Home Tags Generics

Tag: Generics

The Undetected Elephant in the Room: An Analysis of DG Competition’s...

This article is part of a Chronicle. See more from this Chronicle Anthony Dawes, James Killick, Feb 24, 2009 On November 28, 2008, DG Competition's ("DG...

EC’s Preliminary Pharmaceutical Sector Report: An Aggressive Review of Industry Conduct

This article is part of a Chronicle. See more from this Chronicle Susan Creighton, Seth Silber, Feb 24, 2009 This commentary explores the potential impact of...

The Interplay of Patenting Strategies and Competition Law in the Pharmaceutical...

This article is part of a Chronicle. See more from this Chronicle Kristina Nordlander, Stephen Spinks, Feb 24, 2009 In the presentation of its Preliminary Report...

Pharmaceuticals Sector Inquiry: The European Commission Presents Its Preliminary Findings

This article is part of a Chronicle. See more from this Chronicle Elena Kamilarova, Dominik Schnichels, Feb 24, 2009 On November 28, 2008 the European Commission...

From Walker Process to In re DDAVP: Should Direct Purchasers Have...

This article is part of a Chronicle. See more from this Chronicle Aidan Synnott, Nov 29, 2008 In In re: DDAVP Direct Purchaser Antitrust Litigation, decided...

The EC Pharmaceutical Inquiry: Behind the Headlines, What is the Real...

This article is part of a Chronicle. See more from this Chronicle Thomas Cueni, Nov 12, 2008 While the pharmaceutical sector waits for the European Commission's...

The Pharmaceutical Inquiry: Anything to Report?

This article is part of a Chronicle. See more from this Chronicle Sean-Paul Brankin, Nov 12, 2008 One reaction to the pharmaceuticals sector inquiry, particularly from...

The EC’s Investigation into the Pharmaceutical Sector: Trouble Ahead at the...

This article is part of a Chronicle. See more from this Chronicle David Hull, Nov 12, 2008 Efforts by innovative pharmaceutical companies to protect their markets...

Innovation Markets after Genzyme/Novazyme

This article is part of a Chronicle. See more from this Chronicle Richard Gilbert, Jul 12, 2008 The U.S. Federal Trade Commission alleged adverse effects on...

Comment on the EC’s Pharmaceutical Dawn Raids

This article is part of a Chronicle. See more from this Chronicle Susan Creighton, Scott Russell, Feb 14, 2008 The pharmaceutical industry remains under close examination...
Enable Notifications    OK No thanks